A study of nearly 55,000 participants found that individuals with psychological distress markers before a COVID-19 diagnosis were nearly 1.5 times more likely to show symptoms of post-COVID-19 conditions (commonly referred to as long COVID). Depression, anxiety, worry...
Ketamine has been found to be highly effective for treatment-resistant depression, but its fast-acting effects typically do not last more than one to two weeks. A randomized clinical trial of 154 adults with moderate to severe depression measured how a behavioral...
To understand how environmental disasters impact mental health outcomes, researchers surveyed nearly 2,000 residents from Flint, Michigan five years after the onset of the water crisis. Approximately one quarter of respondents met diagnostic criteria for depression...
Research has shown that treatment of early psychosis improves clinical outcomes. In 2018, the Early Psychosis Intervention Network (EPINET) was established with the aim of conducting practice-oriented research to develop high quality care for treatment of...
New research from Hong Kong examines the effectiveness of schizophrenia treatment approaches by comparing the clinical impacts of long-acting injectable antipsychotics (LAIAs) versus oral antipsychotics. In an analysis of more than 70,000 Chinese individuals with...
A systematic review and meta-analysis of 82 studies involving more than 20,000 people provides further insights into the interaction between psychiatric disorders and physical health at the molecular level. Compared to control individuals, those with psychiatric...
